Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchp3-peptidealzheimersamyloid-betauc-santa-cruz

UC Santa Cruz team reports P3 peptide aggregates faster than amyloid beta

Researchers say the overlooked fragment forms its own amyloid deposits and may harm neurons, arguing both peptides should be studied together.

PR
By Priya Raman · Science Reporter
Oct 14 08:44 ETSource: NewsBytes

The wire

  1. 01Researchers at UC Santa Cruz report that the P3 peptide forms protein clumps faster than amyloid beta and may itself be harmful to neurons, forming distinct amyloid deposits.
  2. 02Decades of Alzheimer's drug development have targeted amyloid beta with limited success, so a second aggregating fragment could change how targets are chosen.
  3. 03The report is early laboratory work; the account gives no sample sizes, assay details or human evidence that P3 drives disease in patients.

From the source

UC Santa Cruz finds P3 peptide may reshape Alzheimer's research

Researchers at UC Santa Cruz have found a largely overlooked peptide, P3, that could be a big deal for understanding and treating Alzheimer's disease.

Read at newsbytesapp.com
PeptiPrescribed peptides from $99/moSee all →